ELIZABETH LOFTUS: Open Payments
NPI 1144059007 · CHEEKTOWAGA, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,068 in 45 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $256 · 2025 $1,068
Food & beverage: $1,068
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 32 | $462 |
| Ferring Pharmaceuticals Inc. | 4 | $189 |
| ABBVIE INC. | 1 | $122 |
| Janssen Biotech, Inc. | 1 | $118 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $72 |
| Teleflex LLC | 1 | $41 |
| Novo Nordisk Inc | 1 | $24 |
| Telix Pharmaceuticals | 1 | $23 |
| 180 Medical, Inc. | 1 | $18 |
Products named: GEMTESA, ADSTILADRIN, BOTOX, RYBREVANT, Nubeqa, UROLIFT, Rivfloza, ILLUCCIX.
Industry payments across NY — which companies pay providers there.
